BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Stelling JM, Travers K, Jones RN, Turner PJ, O'Brien TF, Levy SB. Integrating Escherichia coli antimicrobial susceptibility data from multiple surveillance programs. Emerg Infect Dis 2005;11:873-82. [PMID: 15963282 DOI: 10.3201/eid1106.041160] [Cited by in Crossref: 36] [Cited by in F6Publishing: 41] [Article Influence: 2.1] [Reference Citation Analysis]
Number Citing Articles
1 Holloway K, Mathai E, Gray A; Community-Based Surveillance of Antimicrobial Use and Resistance in Resource-Constrained Settings Project Group. Surveillance of antimicrobial resistance in resource-constrained settings - experience from five pilot projects. Trop Med Int Health 2011;16:368-74. [PMID: 21138508 DOI: 10.1111/j.1365-3156.2010.02696.x] [Cited by in Crossref: 17] [Cited by in F6Publishing: 16] [Article Influence: 1.4] [Reference Citation Analysis]
2 Chedea VS, Braicu C, Chirilă F, Ogola HJ, Pelmuş RŞ, Călin LG, Socaciu C. Antioxidant/Prooxidant and antibacterial/probacterial effects of a grape seed extract in complex with lipoxygenase. Biomed Res Int 2014;2014:313684. [PMID: 25313359 DOI: 10.1155/2014/313684] [Cited by in Crossref: 5] [Cited by in F6Publishing: 6] [Article Influence: 0.6] [Reference Citation Analysis]
3 Yamashita N, Katakawa Y, Tanaka H. Occurrence of antimicrobial resistance bacteria in the Yodo River basin, Japan and determination of beta-lactamases producing bacteria. Ecotoxicology and Environmental Safety 2017;143:38-45. [DOI: 10.1016/j.ecoenv.2017.04.053] [Cited by in Crossref: 16] [Cited by in F6Publishing: 10] [Article Influence: 3.2] [Reference Citation Analysis]
4 Borg MA, van de Sande-Bruinsma N, Scicluna E, de Kraker M, Tiemersma E, Monen J, Grundmann H; ARMed Project Members and Collaborators. Antimicrobial resistance in invasive strains of Escherichia coli from southern and eastern Mediterranean laboratories. Clin Microbiol Infect 2008;14:789-96. [PMID: 18727803 DOI: 10.1111/j.1469-0691.2008.02037.x] [Cited by in Crossref: 11] [Cited by in F6Publishing: 11] [Article Influence: 0.8] [Reference Citation Analysis]
5 Greer LG, Roberts SW, Sheffield JS, Rogers VL, Hill JB, Mcintire DD, Wendel GD Jr. Ampicillin resistance and outcome differences in acute antepartum pyelonephritis. Infect Dis Obstet Gynecol 2008;2008:891426. [PMID: 18923674 DOI: 10.1155/2008/891426] [Cited by in Crossref: 4] [Cited by in F6Publishing: 5] [Article Influence: 0.3] [Reference Citation Analysis]
6 Barie PS. The cost of failure. Surg Infect (Larchmt) 2008;9:313-5. [PMID: 18570572 DOI: 10.1089/sur.2007.9964] [Cited by in Crossref: 8] [Cited by in F6Publishing: 6] [Article Influence: 0.6] [Reference Citation Analysis]
7 Blaettler L, Mertz D, Frei R, Elzi L, Widmer AF, Battegay M, Flückiger U. Secular trend and risk factors for antimicrobial resistance in Escherichia coli isolates in Switzerland 1997-2007. Infection 2009;37:534-9. [PMID: 20013094 DOI: 10.1007/s15010-009-8457-0] [Cited by in Crossref: 29] [Cited by in F6Publishing: 24] [Article Influence: 2.4] [Reference Citation Analysis]
8 Ashley EA, Recht J, Chua A, Dance D, Dhorda M, Thomas NV, Ranganathan N, Turner P, Guerin PJ, White NJ, Day NP. An inventory of supranational antimicrobial resistance surveillance networks involving low- and middle-income countries since 2000. J Antimicrob Chemother 2018;73:1737-49. [PMID: 29514279 DOI: 10.1093/jac/dky026] [Cited by in Crossref: 28] [Cited by in F6Publishing: 25] [Article Influence: 9.3] [Reference Citation Analysis]
9 Kronvall G. Antimicrobial resistance 1979-2009 at Karolinska hospital, Sweden: normalized resistance interpretation during a 30-year follow-up on Staphylococcus aureus and Escherichia coli resistance development: ANTIMICROBIAL RESISTANCE 1979-2009 IN STOCKHOLM. APMIS 2010;118:621-39. [DOI: 10.1111/j.1600-0463.2010.02660.x] [Cited by in Crossref: 23] [Cited by in F6Publishing: 22] [Article Influence: 1.9] [Reference Citation Analysis]
10 Lagacé-wiens PR, Simner PJ, Forward KR, Tailor F, Adam HJ, Decorby M, Karlowsky J, Hoban DJ, Zhanel GG. Analysis of 3789 in- and outpatient Escherichia coli isolates from across Canada—results of the CANWARD 2007–2009 study. Diagnostic Microbiology and Infectious Disease 2011;69:314-9. [DOI: 10.1016/j.diagmicrobio.2010.10.027] [Cited by in Crossref: 18] [Cited by in F6Publishing: 18] [Article Influence: 1.6] [Reference Citation Analysis]
11 Zawahir S, Lekamwasam S, Halvorsen KH, Rose G, Aslani P. Self-medication Behavior with antibiotics: a national cross-sectional survey in Sri Lanka. Expert Rev Anti Infect Ther 2021;:1-11. [PMID: 33792479 DOI: 10.1080/14787210.2021.1911647] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
12 Dalhoff A. Resistance surveillance studies: a multifaceted problem--the fluoroquinolone example. Infection. 2012;40:239-262. [PMID: 22460782 DOI: 10.1007/s15010-012-0257-2] [Cited by in Crossref: 68] [Cited by in F6Publishing: 62] [Article Influence: 6.8] [Reference Citation Analysis]
13 Raji MA, Jamal W, Ojemhen O, Rotimi VO. Point-surveillance of antibiotic resistance in Enterobacteriaceae isolates from patients in a Lagos Teaching Hospital, Nigeria. J Infect Public Health 2013;6:431-7. [PMID: 23999335 DOI: 10.1016/j.jiph.2013.05.002] [Cited by in Crossref: 17] [Cited by in F6Publishing: 13] [Article Influence: 1.9] [Reference Citation Analysis]
14 Takahata S, Ida T, Hiraishi T, Sakakibara S, Maebashi K, Terada S, Muratani T, Matsumoto T, Nakahama C, Tomono K. Molecular mechanisms of fosfomycin resistance in clinical isolates of Escherichia coli. Int J Antimicrob Agents. 2010;35:333-337. [PMID: 20071153 DOI: 10.1016/j.ijantimicag.2009.11.011] [Cited by in Crossref: 120] [Cited by in F6Publishing: 108] [Article Influence: 10.0] [Reference Citation Analysis]
15 Huttner A, Bielicki J, Clements MN, Frimodt-Møller N, Muller AE, Paccaud JP, Mouton JW. Oral amoxicillin and amoxicillin-clavulanic acid: properties, indications and usage. Clin Microbiol Infect 2020;26:871-9. [PMID: 31811919 DOI: 10.1016/j.cmi.2019.11.028] [Cited by in Crossref: 18] [Cited by in F6Publishing: 14] [Article Influence: 6.0] [Reference Citation Analysis]
16 Jones RN, Mendes C, Turner PJ, Masterton R. An overview of the Meropenem Yearly Susceptibility Test Information Collection (MYSTIC) Program: 1997-2004. Diagn Microbiol Infect Dis 2005;53:247-56. [PMID: 16360548 DOI: 10.1016/j.diagmicrobio.2005.10.006] [Cited by in Crossref: 32] [Cited by in F6Publishing: 32] [Article Influence: 2.0] [Reference Citation Analysis]
17 Delory T, Le Bel J, Lariven S, Peiffer-Smadja N, Lescure FX, Bouvet E, Jeanmougin P, Tubach F, Boëlle PY. Computerized decision support system (CDSS) use for surveillance of antimicrobial resistance in urinary tract infections in primary care. J Antimicrob Chemother 2021:dkab392. [PMID: 34747446 DOI: 10.1093/jac/dkab392] [Reference Citation Analysis]
18 Tellado JM. The Need for New Antimicrobials for Intra-Abdominal Infections (IAI): Defining the Forthcoming Scenario. Surgical Infections 2006;7:1-4. [DOI: 10.1089/sur.2006.7.1] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.2] [Reference Citation Analysis]
19 Céspedes A, Larson E. Knowledge, attitudes, and practices regarding antibiotic use among Latinos in the United States: review and recommendations. Am J Infect Control 2006;34:495-502. [PMID: 17015154 DOI: 10.1016/j.ajic.2006.01.005] [Cited by in Crossref: 28] [Cited by in F6Publishing: 26] [Article Influence: 1.8] [Reference Citation Analysis]
20 Shehabi A, Odeh J, Fayyad M. Characterization of Antimicrobial Resistance and Class 1 Integrons Found in Escherichia coli Isolates from Human Stools and Drinking Water Sources in Jordan. Journal of Chemotherapy 2013;18:468-72. [DOI: 10.1179/joc.2006.18.5.468] [Cited by in Crossref: 20] [Cited by in F6Publishing: 13] [Article Influence: 2.2] [Reference Citation Analysis]
21 Lagacé-Wiens PR, Decorby MR, Baudry PJ, Hoban DJ, Karlowsky JA, Zhanel GG; CAN-ICU study group. Differences in antimicrobial susceptibility in Escherichia coli from Canadian intensive care units based on regional and demographic variables. Can J Infect Dis Med Microbiol 2008;19:282-6. [PMID: 19436508 DOI: 10.1155/2008/568458] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 0.4] [Reference Citation Analysis]
22 Uchida Y, Mochimaru T, Morokuma Y, Kiyosuke M, Fujise M, Eto F, Eriguchi Y, Nagasaki Y, Shimono N, Kang D. Clonal spread in Eastern Asia of ciprofloxacin-resistant Escherichia coli serogroup O25 strains, and associated virulence factors. Int J Antimicrob Agents 2010;35:444-50. [PMID: 20188525 DOI: 10.1016/j.ijantimicag.2009.12.012] [Cited by in Crossref: 22] [Cited by in F6Publishing: 23] [Article Influence: 1.8] [Reference Citation Analysis]
23 Bebell LM, Muiru AN. Antibiotic use and emerging resistance: how can resource-limited countries turn the tide? Glob Heart 2014;9:347-58. [PMID: 25667187 DOI: 10.1016/j.gheart.2014.08.009] [Cited by in Crossref: 91] [Cited by in F6Publishing: 90] [Article Influence: 11.4] [Reference Citation Analysis]
24 Bojar B, Sheridan J, Beattie R, Cahak C, Liedhegner E, Munoz-Price LS, Hristova KR, Skwor T. Antibiotic resistance patterns of Escherichia coli isolates from the clinic through the wastewater pathway. Int J Hyg Environ Health 2021;238:113863. [PMID: 34662851 DOI: 10.1016/j.ijheh.2021.113863] [Reference Citation Analysis]
25 Boyd LB, Atmar RL, Randall GL, Hamill RJ, Steffen D, Zechiedrich L. Increased fluoroquinolone resistance with time in Escherichia coli from >17,000 patients at a large county hospital as a function of culture site, age, sex, and location. BMC Infect Dis 2008;8:4. [PMID: 18197977 DOI: 10.1186/1471-2334-8-4] [Cited by in Crossref: 39] [Cited by in F6Publishing: 38] [Article Influence: 2.8] [Reference Citation Analysis]
26 Morgan DJ, Okeke IN, Laxminarayan R, Perencevich EN, Weisenberg S. Non-prescription antimicrobial use worldwide: a systematic review. Lancet Infect Dis 2011;11:692-701. [PMID: 21659004 DOI: 10.1016/S1473-3099(11)70054-8] [Cited by in Crossref: 398] [Cited by in F6Publishing: 241] [Article Influence: 36.2] [Reference Citation Analysis]
27 Knowles R, Sharland M, Hsia Y, Magrini N, Moja L, Siyam A, Tayler E. Measuring antibiotic availability and use in 20 low- and middle-income countries. Bull World Health Organ 2020;98:177-187C. [PMID: 32132752 DOI: 10.2471/BLT.19.241349] [Cited by in Crossref: 10] [Cited by in F6Publishing: 7] [Article Influence: 5.0] [Reference Citation Analysis]
28 Hickerson AD, Carson CC. The treatment of urinary tract infections and use of ciprofloxacin extended release. Expert Opin Investig Drugs 2006;15:519-32. [PMID: 16634690 DOI: 10.1517/13543784.15.5.519] [Cited by in Crossref: 8] [Cited by in F6Publishing: 7] [Article Influence: 0.5] [Reference Citation Analysis]
29 Pfaller MA, Diekema DJ, Rinaldi MG, Barnes R, Hu B, Veselov AV, Tiraboschi N, Nagy E, Gibbs DL. Results from the ARTEMIS DISK Global Antifungal Surveillance Study: a 6.5-year analysis of susceptibilities of Candida and other yeast species to fluconazole and voriconazole by standardized disk diffusion testing. J Clin Microbiol. 2005;43:5848-5859. [PMID: 16333066 DOI: 10.1128/jcm.43.12.5848-5859.2005] [Cited by in Crossref: 150] [Cited by in F6Publishing: 49] [Article Influence: 9.4] [Reference Citation Analysis]
30 McGready R, Wuthiekanun V, Ashley EA, Tan SO, Pimanpanarak M, Viladpai-Nguen SJ, Jesadapanpong W, Blacksell SD, Proux S, Day NP, Singhasivanon P, White NJ, Nosten F, Peacock SJ. Diagnostic and treatment difficulties of pyelonephritis in pregnancy in resource-limited settings. Am J Trop Med Hyg 2010;83:1322-9. [PMID: 21118943 DOI: 10.4269/ajtmh.2010.10-0332] [Cited by in Crossref: 8] [Cited by in F6Publishing: 6] [Article Influence: 0.7] [Reference Citation Analysis]
31 Akingbade O, Balogun S, Ojo D, Akinduti P, Okerentugba PO, Nwanze JC, Okonko IO. Resistant plasmid profile analysis of multidrug resistant Escherichia coli isolated from urinary tract infections in Abeokuta, Nigeria. Afr Health Sci 2014;14:821-8. [PMID: 25834489 DOI: 10.4314/ahs.v14i4.8] [Cited by in Crossref: 7] [Cited by in F6Publishing: 6] [Article Influence: 1.0] [Reference Citation Analysis]
32 Al Sweih N, Al Hashem G, Jamal W, Rotimi V. National surveillance of antimicrobial susceptibility of CTX-M-positive and -negative clinical isolates of Escherichia coli from Kuwait government hospitals. J Chemother 2010;22:254-8. [PMID: 20685629 DOI: 10.1179/joc.2010.22.4.254] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 0.4] [Reference Citation Analysis]
33 Ferreira da Silva M, Vaz-Moreira I, Gonzalez-Pajuelo M, Nunes OC, Manaia CM. Antimicrobial resistance patterns in Enterobacteriaceae isolated from an urban wastewater treatment plant. FEMS Microbiol Ecol 2007;60:166-76. [PMID: 17250754 DOI: 10.1111/j.1574-6941.2006.00268.x] [Cited by in Crossref: 165] [Cited by in F6Publishing: 149] [Article Influence: 11.0] [Reference Citation Analysis]
34 Pépin J, Plamondon M, Lacroix C, Alarie I. Emergence of and risk factors for ciprofloxacin-gentamicin-resistant Escherichia coli urinary tract infections in a region of Quebec. Can J Infect Dis Med Microbiol 2009;20:e163-8. [PMID: 21119795 DOI: 10.1155/2009/971624] [Cited by in Crossref: 9] [Cited by in F6Publishing: 7] [Article Influence: 0.8] [Reference Citation Analysis]
35 Both L, Botgros R, Cavaleri M. Analysis of licensed over-the-counter (OTC) antibiotics in the European Union and Norway, 2012. Euro Surveill 2015;20:30002. [PMID: 26530125 DOI: 10.2807/1560-7917.ES.2015.20.34.30002] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 0.5] [Reference Citation Analysis]
36 Epstein BJ, Gums JG, Turner PJ, Feldgarden M, Hou W. Integrating Susceptibility Data from Two Surveillance Programs with Unique Methodological Techniques: The Antibiogram Resistance Method or Isolate-Based Resistance Monitoring (ARMOR) Study Group. Hosp Pharm 2007;42:435-46. [DOI: 10.1310/hpj4205-435] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.2] [Reference Citation Analysis]
37 Masterton R. The importance and future of antimicrobial surveillance studies. Clin Infect Dis. 2008;47 Suppl 1:S21-S31. [PMID: 18713046 DOI: 10.1086/590063] [Cited by in Crossref: 31] [Cited by in F6Publishing: 31] [Article Influence: 2.2] [Reference Citation Analysis]
38 Miajlovic H, Cooke NM, Moran GP, Rogers TR, Smith SG. Response of extraintestinal pathogenic Escherichia coli to human serum reveals a protective role for Rcs-regulated exopolysaccharide colanic acid. Infect Immun 2014;82:298-305. [PMID: 24166954 DOI: 10.1128/IAI.00800-13] [Cited by in Crossref: 36] [Cited by in F6Publishing: 26] [Article Influence: 4.0] [Reference Citation Analysis]
39 Olofsson M, Toepfer M, Östgren CJ, Midlöv P, Matussek A, Lindgren P, Mölstad S. Low level of antimicrobial resistance in Escherichia coli among Swedish nursing home residents. Scandinavian Journal of Infectious Diseases 2012;45:117-23. [DOI: 10.3109/00365548.2012.717232] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 0.8] [Reference Citation Analysis]
40 Lohiya A, Kant S, Kapil A, Gupta SK, Misra P, Rai SK. Pattern of Antibiotic Resistance Among Community Derived Isolates of Enterobacteriaceae Using Urine Sample: A Study From Northern India. J Clin Diagn Res 2015;9:LC15-9. [PMID: 26393150 DOI: 10.7860/JCDR/2015/14230.6254] [Cited by in Crossref: 3] [Cited by in F6Publishing: 5] [Article Influence: 0.4] [Reference Citation Analysis]
41 Soe MM, Edwards JR, Sievert DM, Ricks PM, Magill SS, Fridkin SK. Evaluating state-specific antibiotic resistance measures derived from central line-associated bloodstream infections, national healthcare safety network, 2011. Infect Control Hosp Epidemiol 2015;36:54-64. [PMID: 25627762 DOI: 10.1017/ice.2014.11] [Cited by in Crossref: 6] [Cited by in F6Publishing: 4] [Article Influence: 0.9] [Reference Citation Analysis]